drugset / Trial / NCT02866448
Impact of isoQUercetin and Aspirin on Platelet Function
Withdrawn
University of Reading
Biotechnology and Biological Sciences Research Council · collabQuercegen Pharmaceuticals · collab
RandomizedCrossoverTriple-blindPrevention
Summary
The purpose of this study is to investigate the effect of acute isoquercetin supplementation, aspirin, and isoquercetin/aspirin combination on platelet aggregation, blood pressure and vasculat stiffness (eg digital volume pulse), as well as investigating the plasma accumulation and urine excretion profiles of quercetin.
Timeline
- Start
- 2016-08
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 75 mg | Oral |
| Subject | Isoquercetin | Small molecule | 1000 mg | Oral |